Impax Asset Management Group plc Reduces Holdings in Chemed Corporation $CHE

Impax Asset Management Group plc trimmed its stake in shares of Chemed Corporation (NYSE:CHE) by 5.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 253,182 shares of the company’s stock after selling 14,407 shares during the quarter. Impax Asset Management Group plc owned 1.74% of Chemed worth $113,360,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in CHE. Creekmur Asset Management LLC purchased a new stake in shares of Chemed during the second quarter worth about $28,000. Smartleaf Asset Management LLC lifted its stake in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after acquiring an additional 25 shares during the period. First Horizon Corp purchased a new stake in Chemed during the 3rd quarter valued at $31,000. Parkside Financial Bank & Trust lifted its stake in shares of Chemed by 86.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after purchasing an additional 44 shares during the period. Finally, Geneos Wealth Management Inc. grew its holdings in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares during the period. 95.85% of the stock is owned by institutional investors.

Chemed Stock Up 0.8%

Shares of NYSE CHE opened at $451.73 on Wednesday. The firm has a market cap of $6.40 billion, a P/E ratio of 23.89, a P/E/G ratio of 2.18 and a beta of 0.44. Chemed Corporation has a 52 week low of $408.42 and a 52 week high of $623.60. The business’s 50 day moving average price is $437.45 and its 200 day moving average price is $441.56.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the transaction, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. The trade was a 2.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 3.29% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Jefferies Financial Group downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Royal Bank Of Canada dropped their price objective on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $555.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.